Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community

被引:4
|
作者
Diaz, Javier [1 ]
Martinez, Fernando [1 ,2 ]
Miguel Calderon, Jose [1 ]
Fernandez, Antonio [1 ]
Sauri, Inmaculada [1 ]
Uso, Ruth [1 ]
Luis Trillo, Jose [1 ]
Redon, Josep [1 ,3 ]
Jose Forner, Maria [1 ,2 ]
机构
[1] Univ Valencia, INCLIVA Res Inst, Cardiovasc & Renal Res Grp, Valencia, Spain
[2] Internal Med Hosp Clin Valencia, Valencia, Spain
[3] CIBERObn Carlos III Inst, Madrid, Spain
来源
ESC HEART FAILURE | 2022年 / 9卷 / 06期
关键词
Heart failure; Atrial fibrillation; Hospitalization; Renal function; Stroke; All-cause mortality; CHRONIC KIDNEY-DISEASE; RISK; ASSOCIATIONS; PREDICTORS;
D O I
10.1002/ehf2.14124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The objective of the present study is to assess the bidirectional association between heart failure (HF) and atrial fibrillation (AF) using real-world data. Methods and results From an electronic health recording with a population of 3 799 885 adult subjects, those with prevalent or incident HF were selected and followed throughout a study period of 5 years. Prevalence and incidence of AF, and their impact in the risk for acute HF hospitalization, worsening renal function, ischaemic and haemorrhagic stroke, and all-cause mortality were identified. We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently analysed a subset of patients with incident HF and AF, 57 354 patients (S2). We analysed all incident and prevalent patients with HF and AF, 128 086 patients (S1), and subsequently a subset of patients with incident HF and AF, 57 354 patients (S2). The prevalence of AF was 59 906 (46.7%) of the HF patients, while incidence in the 52 was 231/1000 patients/year. In both cohorts, S1 and S2, AF significantly increases the risk of acute heart failure hospitalization [incidence 79.1/1000 and 97.5/1000 patients/year; HR 1.53 (1.48-1.59 95% CI) and HR 1.32 (1.24-1.41 95% CI), respectively], risk of decreased renal function (eGFR reduced by >20%) [66.2/1000 and 94.0/1000 patients/year; HR 1.13 (1.09-1.18 95% CI) and HR 1.22 (1.14-1.31 95% CI), respectively] and all-cause mortality [203/1000 and 294/1000 patients/year; HR 1.62 (1.58-1.65 95% CI) and HR 1.65 (1.59-1.70 95% CI), respectively]. The number of episodes of hospitalization for acute heart failure was also significantly higher in the AF patients (27 623 vs. 10 036, P < 0.001). However, the risk for ischaemic stroke was reduced in the AF subjects [HR 0.66 (0.63-0.74 95% Cl)), probably due to the anticoagulant treatment. Conclusions AF is associated with an increment in the risk of episodes of acute heart failure as well as decline of renal function and increment of all-cause mortality.
引用
收藏
页码:4230 / 4239
页数:10
相关论文
共 50 条
  • [21] Edoxaban Anticoagulation in Atrial Fibrillation: Real-World Data and Evidence
    Cay, Serkan
    Kasap, Mithat
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2023, 51 (08): : 565 - 573
  • [22] Impact of type 2 diabetes on incidence and phenotype of heart failure in patients with atrial fibrillation
    Polovina, M.
    Milinkovic, I.
    Krljanac, G.
    Veljic, I.
    Petrovic-Djordjevic, I.
    Djikic, D.
    Simic, J.
    Pavlovic, A.
    Kovacevic, V.
    Asanin, M.
    Seferovic, P. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1929 - 1929
  • [23] Economic impact of the reduced incidence of atrial fibrillation in patients with heart failure treated with enalapril
    Wagner, M
    Rindress, D
    Desjardins, B
    Meilleur, MC
    Ducharme, A
    Tardif, JC
    AMERICAN HEART JOURNAL, 2005, 150 (05) : 985.e1 - 985.e8
  • [24] The impact of heart failure on the incidence of stroke in patients with atrial fibrillation: the Fushimi AF Registry
    Iguchi, M.
    Tezuka, Y.
    Masunaga, N.
    Ishii, M.
    Esato, M.
    Chun, Y.
    Wada, H.
    Hasegawa, K.
    Ogawa, H.
    Abe, M.
    Akao, M.
    EUROPEAN HEART JOURNAL, 2016, 37 : 925 - 925
  • [25] Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data
    Buckley, Benjamin J. R.
    Harrison, Stephanie L.
    Gupta, Dhiraj
    Fazio-Eynullayeva, Elnara
    Underhill, Paula
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (23):
  • [26] ALLOPURINOL DECREASES THE INCIDENCE OF ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS
    Hernandez, Fernando Enrique
    Tamariz, Leonardo
    Hare, Joshua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E409 - E409
  • [27] Prevalence and Incidence of Atrial Fibrillation in Ambulatory Patients With Heart Failure
    Pellicori, Pierpaolo
    Urbinati, Alessia
    Kaur, Kuldeep
    Zhang, Jufen
    Shah, Parin
    Kazmi, Syed
    Capucci, Alessandro
    Cleland, John G. F.
    Clark, Andrew L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (10): : 1554 - 1560
  • [28] Incidence of ventricular tachycardia and fibrillation detected by an insertable cardiac monitor in a large real-world cohort of heart failure patients with reduced and preserved ejection fraction
    Kahwash, Rami
    Zile, Michael
    Khan, Mohammad
    Sarkar, Shantanu
    Van Dorn, Brian
    Gerritse, Bart
    Butler, Javed
    CIRCULATION, 2024, 150
  • [29] Real-world variability in dabigatran levels in patients with atrial fibrillation
    Chan, N. C.
    Coppens, M.
    Hirsh, J.
    Ginsberg, J. S.
    Weitz, J. I.
    Vanassche, T.
    Douketis, J. D.
    Schulman, S.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (03) : 353 - 359
  • [30] Impact of atrial fibrillation on the accuracy of oscillometric blood pressure monitoring in ICU patients from a large real-world database
    Li, Yuxi
    Wang, Beining
    Fan, Fangfang
    Weng, Haoyu
    Zhang, Long
    Jiang, Jie
    Zheng, Bo
    Zhang, Yan
    Li, Jianping
    JOURNAL OF HYPERTENSION, 2023, 41 (05) : 838 - 844